FDA Approves Use of NEXIUM(R) in Children With GERD
Monday May 1, 2006
AstraZeneca announced today that the U.S. Food and Drug Administration (FDA) has approved the use of NEXIUM® (esomeprazole magnesium) delayed release capsules, in children ages 12 to 17 for the Read More...

